EVGN
Evogene
NASDAQ: EVGN · HEALTHCARE · BIOTECHNOLOGY
$0.78
+2.88% today
Updated 2026-04-30
Market cap
$9.54M
P/E ratio
—
P/S ratio
2.48x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Evogene (EVGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-56.1%
Last 4 quarters
Revenue YoY growth
-80.5%
Most recent quarter
EPS YoY growth
-1129.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.7%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-8.4%
2026-03-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.62 | -50.6% | $0.84 | $0.77 | -8.4% |
| 2025-11-20 | $-0.31 | +27.9% | $1.17 | $1.13 | -3.4% |
| 2025-09-30 | $-0.62 | -1.6% | $1.18 | $1.15 | -2.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.41 | $-0.62 | -50.6% | $314000.00 | -80.5% |
| 2025-09-30 | $-0.43 | $-0.31 | +27.9% | $312000.00 | -82.1% |
| 2025-06-30 | $-0.61 | $-0.62 | -1.6% | $884000.00 | +46.1% |
| 2025-03-31 | $-0.09 | $-0.38 | -322.2% | $2.44M | -41.7% |
| 2024-12-31 | $-0.73 | $0.06 | +108.3% | $1.61M | +178.7% |
| 2024-09-30 | $-1.01 | $-1.31 | -29.7% | $1.74M | -53.8% |
| 2024-06-30 | $-0.12 | $-1.06 | -783.3% | $605000.00 | -7.5% |
| 2024-03-31 | $-0.09 | $-0.08 | +11.1% | $4.19M | +553.7% |
| 2023-12-31 | $-0.14 | $-0.13 | +7.1% | $578000.00 | — |
| 2023-09-30 | $-0.16 | $-0.08 | +50.0% | $3.77M | — |
| 2023-06-30 | $-0.17 | $-0.17 | +0.0% | $654000.00 | — |
| 2023-03-31 | $-0.16 | $-0.15 | +6.3% | $641000.00 | — |
| 2022-12-31 | $-0.20 | $-0.07 | +65.0% | — | — |
Frequently asked questions
Has Evogene beaten earnings estimates?
Evogene has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -56.1% over the last 4 quarters.
How does EVGN stock react to earnings?
EVGN stock has moved an average of -4.7% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Evogene's revenue growth rate?
Evogene reported year-over-year revenue growth of -80.5% in its most recent quarter, with EPS growing -1129.0% year-over-year.